EyeBio
eyebiotech.comLocations
London, UK · New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2021
Eyebiotech is a vision treatment company that develops products to preserve, repair, and improve eyesight. The firm guards against sight-threatening eye disorders and developed the first anti-vascular endothelial growth factor medication for patients with age-related macular degeneration, allowing those with eye ailments to regain their eyesight.
Something looks off?Open jobs at EyeBio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.